Gufic Biosciences Limited (GUFICBIO.BO)
INR 449.05
(0.28%)
INR 449.05
(0.28%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 8.06 Billion | 6.9 Billion | 7.79 Billion | 4.87 Billion | 3.78 Billion | 3.5 Billion |
| Cost of Revenue | 3.89 Billion | 3.31 Billion | 4.11 Billion | 2.57 Billion | 1.86 Billion | 1.81 Billion |
| Gross Profit | 4.16 Billion | 3.58 Billion | 3.67 Billion | 2.29 Billion | 1.91 Billion | 1.68 Billion |
| Operating Expenses | 1.07 Billion | 2.46 Billion | 2.38 Billion | 1.61 Billion | 1.52 Billion | 1.26 Billion |
| Selling, General and Administrative Expenses | 1.05 Billion | 822.82 Million | 176.05 Million | 110.6 Million | 111.38 Million | 85.1 Million |
| Research and Development Expenses | - | 51.55 Million | 44.28 Million | 20.98 Million | 20 Million | 20.77 Million |
| Other Expenses | 21.77 Million | 25.73 Million | 31.04 Million | 2.74 Million | 32.99 Million | 20.91 Million |
| Cost and Expenses | 6.73 Billion | 5.78 Billion | 6.5 Billion | 4.19 Billion | 3.39 Billion | 3.08 Billion |
| Operating Income | 1.32 Billion | 1.17 Billion | 1.29 Billion | 684.66 Million | 400.86 Million | 417.34 Million |
| Interest Expense | 153.59 Million | 82.23 Million | 53.65 Million | 117.65 Million | 126.78 Million | 100.26 Million |
| Income Tax Expense | 295.35 Million | 270.16 Million | 309.98 Million | 134.79 Million | 74.38 Million | 134.08 Million |
| Earnings before Tax | 1.15 Billion | 1.06 Billion | 1.26 Billion | 577.11 Million | 301.26 Million | 353.49 Million |
| Net Income | 861.35 Million | 797.04 Million | 958.4 Million | 442.31 Million | 226.87 Million | 219.4 Million |
| Earnings Per Share Basic | 8.74 | 8.22 | 9.89 | 4.56 | 2.34 | 2.82 |
| Earnings Per Share Diluted | 8.74 | 8.22 | 9.89 | 4.56 | 2.34 | 2.82 |
| Weighted Average Shares Outstanding | 98.55 Million | 96.94 Million | 96.94 Million | 96.94 Million | 96.94 Million | 77.83 Million |
| Weighted Average Shares Outstanding (Diluted) | 98.55 Million | 96.94 Million | 96.94 Million | 96.94 Million | 96.94 Million | 77.83 Million |
| Gross Margin | 0.52 | 0.52 | 0.47 | 0.47 | 0.51 | 0.48 |
| EBIT Margin | 0.18 | 0.20 | 0.19 | 0.18 | 0.15 | 0.14 |
| Profit Margin | 0.11 | 0.12 | 0.12 | 0.09 | 0.06 | 0.06 |
| EBITDA | 1.48 Billion | 1.37 Billion | 1.48 Billion | 876.52 Million | 579.04 Million | 489.98 Million |
| Earnings Before Tax Margin | 0.16 | 0.17 | 0.17 | 0.14 | 0.11 | 0.12 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 2.02 Billion | 8.06 Billion | 2.01 Billion | 2.01 Billion | 2.14 Billion | 1.95 Billion |
| Cost of Revenue | 1.28 Billion | 5.16 Billion | 1.3 Billion | 953.35 Million | 1.09 Billion | 968.39 Million |
| Gross Profit | 747.21 Million | 2.9 Billion | 716.97 Million | 1.06 Billion | 1.05 Billion | 981.8 Million |
| Operating Expenses | 432.47 Million | 1.61 Billion | 393.84 Million | 741.29 Million | 706.97 Million | 669.39 Million |
| Selling, General and Administrative Expenses | 432.47 Million | - | 393.84 Million | 393.84 Million | 396.18 Million | 393.3 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 12.54 Million | 21.77 Million | 8.81 Million | 4.23 Million | 3.34 Million | 8.81 Million |
| Cost and Expenses | 1.71 Billion | 6.77 Billion | 1.69 Billion | 1.69 Billion | 1.79 Billion | 1.63 Billion |
| Operating Income | 314.74 Million | 1.28 Billion | 323.13 Million | 327.36 Million | 350.72 Million | 312.4 Million |
| Interest Expense | 46.24 Million | 153.59 Million | 36.47 Million | 31.78 Million | 44.61 Million | 40.72 Million |
| Income Tax Expense | 72.48 Million | 295.36 Million | 73 Million | 73 Million | 77.35 Million | 74.26 Million |
| Earnings before Tax | 281.04 Million | 1.15 Billion | 295.57 Million | 295.57 Million | 309.45 Million | 280.49 Million |
| Net Income | 208.56 Million | 861.35 Million | 200.45 Million | 222.57 Million | 232.09 Million | 206.22 Million |
| Earnings Per Share Basic | 2.08 | - | 2.23 | 2.22 | 2.39 | 2.13 |
| Earnings Per Share Diluted | 2.08 | - | 2.23 | 2.22 | 2.39 | 2.13 |
| Weighted Average Shares Outstanding | 100.27 Million | 100.27 Million | 100.27 Million | 100.27 Million | 96.94 Million | 96.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 100.27 Million | 100.27 Million | 100.27 Million | 100.27 Million | 96.94 Million | 96.94 Million |
| Gross Margin | 0.37 | 0.36 | 0.36 | 0.53 | 0.49 | 0.50 |
| EBIT Margin | 0.18 | - | 0.18 | 0.18 | 0.18 | 0.19 |
| Profit Margin | 0.10 | 0.11 | 0.10 | 0.11 | 0.11 | 0.11 |
| EBITDA | 357.79 Million | - | 364.54 Million | 368.78 Million | 397.03 Million | 363.58 Million |
| Earnings Before Tax Margin | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 | 0.16 |
002790
LSPK
AUST
SLMN
MKP
7155